At what age should autism screening be initiated in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Autism Screening Should Begin at 18 and 24 Months of Age

All children should receive autism-specific screening at both the 18-month and 24-month well-child visits. This recommendation is based on strong guideline evidence from the American Academy of Pediatrics and supported by extensive validation studies 1.

Primary Screening Ages

The evidence clearly supports two mandatory screening timepoints:

  • 18 months: First autism-specific screen
  • 24 months: Second autism-specific screen

Both screenings are necessary because 1:

  • Screening at 18 months may have higher false-positive rates but captures early-emerging cases
  • Screening at 24 months improves accuracy and identifies children with later symptom onset or regression after 18 months
  • Combined screening at both ages optimizes detection while maintaining acceptable specificity

Why Not Earlier?

Screening before 18 months is not currently recommended for routine practice 1:

  • Tools tested at 12-15 months show poor sensitivity (only detecting 4 of 9 cases in one study)
  • The ESAT screener at 14-15 months had very low positive predictive value (0.25), meaning 75% of positive screens were false alarms
  • Recent 2026 data confirms that screeners used at 6-12 months have poor psychometric properties (AUC < 0.70) 2
  • Autism symptoms emerge gradually across the first 24 months, making earlier detection inherently less reliable

Recommended Screening Tool

The Modified Checklist for Autism in Toddlers, Revised with Follow-Up (M-CHAT-R/F) has the strongest evidence base 1:

  • In the largest validation study (N=18,989 toddlers aged 18-30 months), the M-CHAT-R showed:
    • Positive predictive value of 0.54 for ASD specifically
    • Positive predictive value of 0.98 for ANY developmental disorder
  • Critical implementation detail: The follow-up interview component is essential—without it, PPV drops to only 0.058 (meaning 94% false positives)

Special Population: High-Risk Siblings

Children with an older sibling diagnosed with autism require intensified surveillance plus screening at 18 and 24 months 1:

  • Recurrence risk is 14-18% (compared to general population risk of ~1.7%)
  • These children need continuous developmental monitoring between visits, not just screening at standard ages
  • Earlier concerns about social communication, cognition, or behavior should trigger immediate referral regardless of screening results

What Happens After a Positive Screen

Immediate dual referral is mandatory 1:

  1. Schedule comprehensive diagnostic evaluation (do not wait for the evaluation to refer to #2)
  2. Refer concurrently to early intervention services

This parallel approach ensures children begin receiving services while awaiting formal diagnosis, as diagnostic evaluations often have substantial wait times.

Diagnostic Stability Considerations

Diagnoses made as early as 14 months show good stability 1:

  • 85-93% stability for autistic disorder diagnoses before 24 months
  • 47-62% stability for milder presentations (PDD-NOS)
  • This supports the validity of early screening and diagnosis, though milder cases require closer monitoring

Common Clinical Context

Recent evidence shows that 80% of children with positive autism screens already have documented developmental concerns in their medical record 3:

  • Average of 2 documented concerns by age 12 months
  • Average of 3 concerns by age 24 months
  • Prior concerns often include language delays, motor delays, sleep problems, or gastrointestinal issues

This means screening typically occurs within existing conversations about development, making the discussion less stigmatizing and more confirmatory of parental observations.

Critical Implementation Pitfall

Do not screen once and assume you're done. The evidence strongly supports screening at BOTH 18 and 24 months 1, 2:

  • Single-timepoint screening misses cases with later onset or regression
  • Using multiple screeners or screening longitudinally achieves "good" psychometric performance (AUC ≥ 0.80)
  • Screening at only one age reduces overall detection rates

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.